研究报告

骨质疏松易感SNP rs4325274通过增强子远程调控SOX6基因的功能机制研究

展开
  • 1. 西安交通大学生命科学与技术学院,生物医学信息工程教育部重点实验室,生物医学信息与基因组学中心,西安 710049
    2. 浙江西安交通大学研究院,杭州 311215
妥晓梅,在读硕士研究生,专业方向:疾病分子遗传机制的基础研究。E-mail: xmt18392079044@stu.xjtu.edu.cn

收稿日期: 2020-05-26

  修回日期: 2020-09-04

  网络出版日期: 2020-09-07

基金资助

国家自然科学基金面上项目编号(31771399);国家自然科学基金面上项目编号(31970569);中国博士后基金项目编号(2019M650261);陕西省自然科学基础研究计划项目编号(2020JQ-026);浙江省自然科学基金资助编号(GF18C060003)

The osteoporosis susceptible SNP rs4325274 remotely regulates the SOX6 gene through enhancers

Expand
  • 1. Biomedical Informatics & Genomics Center, Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049;
    2. Research Institute of Zhejiang Xi'an Jiaotong University, Hangzhou 311215

Received date: 2020-05-26

  Revised date: 2020-09-04

  Online published: 2020-09-07

Supported by

Supported by the National Natural Science Foundation of China No(31771399);Supported by the National Natural Science Foundation of China No(31970569);China PostdoctoralScience Foundation No(2019M650261);Natural Science Basic Research Plan in Shaanxi Province of China No(2020JQ-026);the Zhejiang Provincial Natural Science Foundation of China No(GF18C060003)

摘要

骨质疏松症是一种典型的多基因复杂疾病,遗传力高达85%,其发病率已跃居常见疾病的第5位。尽管已经鉴定出大量骨质疏松易感SNP,但大多数SNP位点位于基因组非编码区,且功能机制未知。本研究旨在通过生物信息学分析和功能实验探究骨质疏松非编码功能性易感SNP rs4325274的分子调控机制。首先,通过表观注释发现该SNP所在区域处在增强子上,eQTL和Hi-C分析结果发现SNP调控的潜在靶基因是SOX6;然后,利用多种数据库进行Motif预测,并结合GEO数据库中的ChIP-seq数据分析进行了验证,结果发现转录因子HNF1A更倾向于结合SNP rs4325274-G碱基;进一步通过双荧光素酶报告基因实验验证了该SNP对SOX6基因表达的增强作用;最后,利用shRNA敲低转录因子HNF1A实验,检测靶基因SOX6的表达变化。以上研究结果初步解析了非编码区功能性SNPrs4325274作为增强子远程调控SOX6基因表达的分子机制,为复杂疾病非编码易感SNP的遗传调控研究提供新思路。

本文引用格式

妥晓梅, 朱东丽, 陈晓峰, 荣誉, 郭燕, 杨铁林 . 骨质疏松易感SNP rs4325274通过增强子远程调控SOX6基因的功能机制研究[J]. 遗传, 2020 , 42(9) : 889 -897 . DOI: 10.16288/j.yczz.20-098

Abstract

Osteoporosis is a typical polygenic disease, and its heritability is as high as 85%. The incidence of osteoporosis has jumped to the fifth among the common diseases. Although a large number of osteoporosis-susceptible SNPs have been identified, most of them are in the non-coding regions of the genome and the functional mechanisms are unknown. The purpose of this study was to explore the function of non-coding osteoporosis-susceptible SNP rs4325274 and dissect the molecular regulatory mechanisms through integrating bioinformatics analysis and functional experiments. Firstly, we found the SNP rs4325274 resided in a putative enhancer element through functional annotation. eQTL and Hi-C analysis found that the SOX6 gene might be a potential distal target of rs4325274. We conducted the motif prediction using multiple databases and verified the result using ChIP-seq data from GEO database. The result showed that the transcription factor HNF1A could preferentially bind to SNP rs4325274-G allele. We further demonstrated that SNP rs4325274 acted as an enhancer regulating SOX6 gene expression by using dual-luciferase reporter assays. Knockdown of HNF1A decreased the SOX6 gene expression. Taken together, our results uncovered a new mechanism of a non-coding functional SNP rs4325274 as a distal enhancer to modulate SOX6 expression, which provides new insights into deciphering molecular regulatory mechanisms underlying non-coding susceptibility SNPs on complex diseases.

参考文献

[1] Lamichhane AP . Osteoporosis-an update. JNMA J Nepal Med Assoc, 2005,44(158):60-66.
[2] Reginster JY, Burlet N . Osteoporosis: a still increasing prevalence. Bone, 2006,38(2 Suppl. 1):S4-9.
[3] Morales-Torres J , Gutiérrez-Ure?aS.The burden of osteoporosis in latinamerica. OsteoporosInt, 2004,15(8):625-632.
[4] Nguyen TV, Center JR, Eisman JA . Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust, 2004,180(S5):S18-22.
[5] Smits P, Li P, Mandel J, Zhang ZP, Deng JM, Behringer RR, de Crombrugghe B, Lefebvre V,. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell, 2001,1(2):277-290.
[6] Smits P, Dy P, Mitra S, Lefebvre V . Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol, 2004,164(5):747-758.
[7] Renard E, Porée B, Chadjichristos C, Kypriotou M, Maneix L, Bigot N, Legendre F, Ollitrault D, De Crombrugghe B, Malléin-Gérin F, Moslemi S, Demoor M, Boumediene K, Galéra P . Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med (Berl), 2012,90(6):649-666.
[8] Liu J, Wang HW, Chen Y, Yu HL, Wang Q, Yang HF, Ma JX, Xiang LB . Regulatory effect of SOX6 and SOX9 on the growth and differentiation properties into chondrocytes of MPCs in primary OA articular cartilage. J Reg Anat Oper Surg, 2014, ( 5):477-481.
[8] 刘军, 王洪伟, 陈语, 于海龙, 王琪, 杨会峰, 马骏雄, 项良碧 . SOX6SOX9基因转染对人原发性骨关节炎关节软骨间充质祖细胞增殖和成软骨分化的调控作用. 局解手术学杂志, 2014, ( 5):477-481.
[9] Zhang Y, Yang TL, Li X, Guo Y . Functional analyses reveal the essential role of SOX6 and RUNX2 in the communication of chondrocyte and osteoblast. OsteoporosInt, 2015,26(2):553-561.
[10] Livshits G, Deng HW, Nguyen TV, Yakovenko K, Recker RR, Eisman JA, . Genetics of bone mineral density: evidence for a major pleiotropic effect from an intercontinental study. J Bone Miner Res, 2004,19(6):914-923.
[11] Peacock M, Turner CH, Econs MJ, Foroud T . Genetics of osteoporosis. Endocr Rev, 2002,23(3):303-326.
[12] Rivadeneira F, Styrkársdottir U, Estrada K, Halldórsson BV, Hsu YH, Richards JB, Zillikens MC, Kavvoura FK, Amin N, Aulchenko YS, Cupples LA, Deloukas P, Demissie S, Grundberg E, Hofman A, Kong A, Karasik D, van Meurs JB, Oostra B, Pastinen T, Pols HA, Sigurdsson G, Soranzo N, Thorleifsson G, Thorsteinsdottir U, Williams FM, Wilson SG, Zhou YH, Ralston SH, van Duijn CM, Spector T, Kiel DP, Stefansson K, Ioannidis JP, Uitterlinden AG. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet, 2009,41(11):1199-1206.
[13] Hsu YH, Zillikens MC, Wilson SG, Farber CR, Demissie S, Soranzo N, Bianchi EN, Grundberg E, Liang LM, Richards JB, Estrada K, Zhou YH, van Nas A, Moffatt MF, Zhai GJ, Hofman A, van Meurs JB, Pols HA, Price RI, Nilsson O, Pastinen T, Cupples LA, Lusis AJ, Schadt EE, Ferrari S, Uitterlinden AG, Rivadeneira F, Spector TD, Karasik D, Kiel DP,. An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet, 2010,6(6):e1000977.
[14] Tan LJ, Liu R, Lei SF, Pan R, Yang TL, Yan H, Pei YF, Yang F, Zhang F, Pan F, Zhang YP, Hu HG, Levy S, Deng HW . A genome-wide association analysis implicates SOX6 as a candidate gene for wrist bone mass. Sci China Life Sci, 2010,53(9):1065-1072.
[15] Villalobos-Comparán M, Jiménez-Ortega RF, Estrada K, Parra-Torres AY, González-Mercado A, Pati?o N, Castillejos- López M, Quiterio M, Fernandez-López JC, Ibarra B, Romero-Hidalgo S, Salmerón J, Velázquez-Cruz R . A pilot genome-wide association study in postmenopausal mexican- mestizo women implicates the RMND1/CCDC170 locus is associated with bone mineral density. Int J Genomics, 2017,2017:5831020.
[16] Morris JA, Kemp JP, Youlten SE, Laurent L, Logan JG, Chai RC, Vulpescu NA, Forgetta V, Kleinman A, Mohanty ST, Sergio CM, Quinn J, Nguyen-Yamamoto L, Luco AL, Vijay J, Simon MM, Pramatarova A, Medina-Gomez C, Trajanoska K, Ghirardello EJ, Butterfield NC, Curry KF, Leitch VD, Sparkes PC, Adoum AT, Mannan NS, Komla-Ebri DSK, Pollard AS, Dewhurst HF, Hassall TAD, Beltejar MG, Adams DJ, Vaillancourt SM, Kaptoge S, Baldock P, Cooper C, Reeve J, Ntzani EE, Evangelou E, Ohlsson C, Karasik D, Rivadeneira F, Kiel DP, Tobias JH, Gregson CL, Harvey NC, Grundberg E, Goltzman D, Adams DJ, Lelliott CJ, Hinds DA, Ackert-Bicknell CL, Hsu YH, Maurano MT, Croucher PI, Williams GR, Bassett JHD, Evans DM, Richards JB . An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet, 2019,51(2):258-266.
[17] Medina-Gomez C, Kemp JP, Trajanoska K, Luan J, Chesi A, Ahluwalia TS, Mook-Kanamori DO, Ham A, Hartwig FP, Evans DS, Joro R, Nedeljkovic I, Zheng HF, Zhu K, Atalay M, Liu CT, Nethander M, Broer L, Porleifsson G, Mullin BH, Handelman SK, Nalls MA, Jessen LE, Heppe DHM, Richards JB, Wang C, Chawes B, Schraut KE, Amin N, Wareham N, Karasik D, Van der Velde N, Ikram MA, Zemel BS, Zhou YH, Carlsson CJ, Liu Y, McGuigan FE, Boer CG, B?nnelykke K, Ralston SH, Robbins JA, Walsh JP, Zillikens MC, Langenberg C, Li-Gao R, Williams FMK, Harris TB, Akesson K, Jackson RD, Sigurdsson G, den Heijer M, van der Eerden BCJ, van de Peppel J, Spector TD, Pennell C, Horta BL, Felix JF, Zhao JH, Wilson SG, de Mutsert R, Bisgaard H, Styrkársdóttir U, Jaddoe VW, Orwoll E, Lakka TA, Scott R, Grant SFA, Lorentzon M, van Duijn CM, Wilson JF, Stefansson K, Psaty BM, Kiel DP, Ohlsson C, Ntzani E, van Wijnen AJ, Forgetta V, Ghanbari M, Logan JG, Williams GR, Bassett JHD, Croucher PI, Evangelou E, Uitterlinden AG, Ackert-Bicknell CL, Tobias JH, Evans DM, Rivadeneira F. Life-Course genome-wide association study meta-analysis of total body BMD and assessment of age-specific effects. Am J Hum Genet, 2018,102(1):88-102.
[18] Chau D, Ng K, Chan TS, Cheng YY, Fong B, Tam S, Kwong YL, Tse E . Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9. J Hematol Oncol, 2015,8:46.
[19] Pelletier L, Rebouissou S, Paris A, Rathahao-Paris E, Perdu E, Bioulac-Sage P, Imbeaud S, Zucman-Rossi J . Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activationof signaling pathways involved in tumorigenesis. Hepatology, 2010,51(2):557-566.
[20] Krijger PHL, de Laat W . Regulation of disease-associated gene expression in the 3D genome. Nat Rev Mol Cell Biol, 2016,17(12):771-782.
[21] Lane JM, Russell L, Khan SN . Osteoporosis. Clin Orthop Relat Res, 2000, ( 327):139-150.
[22] Boudin E, Fijalkowski I, Hendrickx G, Van Hul W . Genetic control of bone mass. Mol Cell Endocrinol, 2016,432:3-13.
[23] Huang QY . Genetic study of complex diseases in the post-GWAS era. J Genet Genomics, 2015,42(3):87-98.
[24] ENCODE Project Consortium . An integrated encyclopedia of DNA elements in the human genome. Nature, 2012,489(7414):57-74.
[25] Ding N, Qu HZ, Fang XD . The ENCODE project and functional genomics studies. Hereditas(Beijing), 2014,36(3):237-247.
[25] 丁楠, 渠鸿竹, 方向东 . ENCODE计划和功能基因组研究. 遗传, 2014,36(3):237-247.
[26] Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, Farnham PJ, Hirst M, Lander ES, Mikkelsen TS, Thomson JA . The NIH roadmap epigenomics mapping consortium. Nat Biotechnol, 2010,28(10):1045-1048.
[27] Kilpinen H, Waszak SM, Gschwind AR, Raghav SK, Witwicki RM, Orioli A, Migliavacca E, Wiederkehr M, Gutierrez-Arcelus M, Panousis NI, Yurovsky A, Lappalainen T, Romano-Palumbo L, Planchon A, Bielser D, Bryois J, Padioleau I, Udin G, Thurnheer S, Hacker D, Core LJ, Lis JT, Hernandez N, Reymond A, Deplancke B, Dermitzakis ET . Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science, 2013,342(6159):744-747.
[28] Xiao SM, Gao Y, Cheung CL, Bow CH, Lau KS, Sham PC, Tan KC, Kung AW . Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk. OsteoporosInt, 2012,23(7):1877-1887.
[29] Xiao SM, Kung AW, Gao Y, Lau KS, Ma A, Zhang ZL, Liu JM, Xia W, He JW, Zhao L, Nie M, Fu WZ, Zhang MJ, Sun J, Kwan JS, Tso GH, Dai ZJ, Cheung CL, Bow CH, Leung AY, Tan KC, Sham PC . Post-genome wide association studies and functional analyses identify association of MPP7 gene variants with site-specific bone mineral density. Hum Mol Genet, 2012,21(7):1648-1657.
[30] Zhu DL, Chen XF, Hu WX, Dong SS, Lu BJ, Rong Y, Chen YX, Chen H, Thynn HN, Wang NN, Guo Y, Yang TL . Multiple functional variants at 13q14 risk locus for osteoporosis regulate RANKL expression through long- range super-enhancer. J Bone Miner Res, 2018,33(7):1335-1346.
文章导航

/